Cervical Ripening in Premature Rupture of Membranes

Brief Summary
Premature rupture of membranes (PROM) is diagnosed by demonstrating amniotic fluid in the vaginal canal before the onset of labor. The integrity of the amniotic membrane is compromised thereby increasing the risk of intrauterine infection and compression of the umbilical cord. PROM complicates 3% to 8% of pregnancies in the US and is responsible for 30% of preterm births. Intrauterine infection remains the most significant maternal and neonatal sequelae associated with PROM and this risk increases with the length of time from ruptured membrane to delivery. Induction of labor has been shown to reduce the rates of chorioamnionitis, endometritis and NICU admissions4. Specifically, induction of labor with prostaglandin agents followed by oxytocin, versus oxytocin alone has been shown to be effective for labor induction resulting in vaginal delivery. Management strategies for PROM have been controversial, and published studies on outcomes are over one to two decades old, which does not account for changes in clinical trends and practice patterns. Recently ACOG recommends that patients presenting at 37 weeks gestation or greater with PROM should be induced if not in labor, and "generally with oxytocin". In women with PROM without the onset of labor, the cervix is commonly unfavorable and induction with oxytocin alone may lead to an increased risk of cesarean section. With a c-section rate as high as 33%, women undergoing induction of labor have an increased risk of c-section and its associated morbidity and long term sequela. ACOG's recommendation for the use of oxytocin as the induction agent may be meant to avoid a theoretical increased risk of chorioamnionitis in this patient population however it does not take into account the status of the cervix, which may result in a increased risk of c-section. The purpose of the proposed study is to determine whether cervical ripening in women with PROM and an unfavorable cervix is associated with increase rates of vaginal delivery and decreased cesarean section rate compared to induction of labor with oxytocin alone. The investigators aim to determine the incidence of endometritis, and neonatal infection associated with PROM in the current medical environment of antibiotic prophylaxis and antenatal steroid use, taking into account the changes in patient characteristics.
Brief Title
Cervical Ripening in Premature Rupture of Membranes
Detailed Description
We will perform a prospective randomized control trial involving women with singleton gestation at ≥ 34 weeks gestation who require an induction of labor after diagnosis of PROM with an unfavorable cervix. PROM will be diagnosed and confirmed with sterile speculum examination demonstrating pooling and/or positive ferning or nitrazine. Cervical status will be assessed by visual exam, digital exam or transvaginal ultrasound to assign a Bishop score (dilation, effacement, station, consistency \& position). Determination of patient eligibility will be based on the clinical exam and confirmation of PROM. Upon diagnosis, if the patient meets inclusion criteria and accepts to participate in the study, they will be consented by the study investigator and then be randomized to prostaglandin followed by oxytocin or oxytocin alone group. Allocation concealment will be performed via the utilization of pre-sequentially numbered, manila sealed envelopes stapled closed.

There are two treatment groups and will be analyzed on an intent-to-treat basis. Randomization will be performed using a computer generated simple randomization sequence. Data safety monitoring will be instituted (see data safety monitoring plan below). Once randomization is completed, the labor and delivery providers will be informed of the treatment arm and this will be placed on the chart. Those randomized to the prostaglandin arm will receive PGE1 (misoprostol) in a dose of 25mcg placed vaginally every 4 hours as per hospital protocol. Those randomized to the oxytocin arm will receive infusion of oxytocin, which will then be titrated per hospital protocol until adequate contractions. Further management after the start of the respective arm will be based on clinical judgment of the provider.
Completion Date
Completion Date Type
Actual
Conditions
Pregnancy
Premature Rupture of Membranes
Preterm Premature Rupture of Membranes
Unfavorable Cervix
Eligibility Criteria
Inclusion Criteria:

1. All pregnant women diagnosed with PROM without evidence of labor requiring induction
2. Gestational Age \> 34 weeks
3. Bishop score \< 6
4. Category I Fetal heart rate tracing

Exclusion Criteria:

1. Contraindication to Induction of Labor
2. Multiple gestation
3. Fetal Anomalies
4. Previous C-Section
5. HIV Positive Patients
Inclusion Criteria
Inclusion Criteria:

1. All pregnant women diagnosed with PROM without evidence of labor requiring induction
2. Gestational Age \> 34 weeks
3. Bishop score \< 6
4. Category I Fetal heart rate tracing

Gender
Female
Gender Based
false
Keywords
Bishop Score
Induction of Labor
Cervical Ripening
Unfavorable Cervix
Mode of Delivery
C-Section
Cesarean Section
Misoprostol
Prostaglandin
Prostaglandin E1
Healthy Volunteers
No
Last Update Submit Date
Maximum Age
50 Years
Minimum Age
15 Years
NCT Id
NCT02314728
Org Class
Other
Org Full Name
Montefiore Medical Center
Org Study Id
2014-3462
Overall Status
Completed
Phases
Not Applicable
Primary Completion Date
Primary Completion Date Type
Actual
Official Title
Cervical Ripening in Premature Rupture of Membranes
Primary Outcomes
Outcome Description
Mode of delivery via cesarean section or vaginal delivery
Outcome Measure
Rate of Cesarean Section
Outcome Time Frame
within 48 hours
Secondary Outcomes
Outcome Description
Maternal infection defined as fever \>100.4 on at least two occasions during labor, continued antibiotic treatment on or after PPD#1, histologic confirmation of chorioamnionitis. Dose of Oxytocin, Tachysystole, Estimated blood loss at delivery, maternal length of stay, Epidural use, Indication for cesarean delivery

Neonatal infection defined as WBC \<5000 and absolute neutrophil count \<1000 or positive blood cultures and neonatal fever, NICU admission, Apgar score less than 7 at 5 minutes,
Outcome Time Frame
within 72 hours
Outcome Measure
Maternal and Neonatal Infectious Morbidity
Start Date
Start Date Type
Actual
Status Verified Date
First Submit Date
First Submit QC Date
Std Ages
Child
Adult
Maximum Age Number (converted to Years and rounded down)
50
Minimum Age Number (converted to Years and rounded down)
15
Investigators
Investigator Type
Principal Investigator
Investigator Name
Kafui Demasio
Investigator Email
kafui5@netzero.net
Investigator Phone